Methodologically appropriate evaluation of continuous BMI as a clinical predictor of chemoimmunotherapy efficacy in advanced non-small cell lung cancer

Background: Multiple studies have indicated that obese and overweight patients may experience favourable survival outcomes during treatment with an immune checkpoint inhibitor (ICI). However, most prior studies evaluated ICI-treated patients without a control cohort, and utilised categorised BMI with inconsistent body mass index (BMI) cut point definitions. Methods: This secondary analysis pooled individual patient data […]